Viewing StudyNCT00490139



Ignite Creation Date: 2024-05-05 @ 6:30 PM
Last Modification Date: 2024-10-26 @ 9:33 AM
Study NCT ID: NCT00490139
Status: COMPLETED
Last Update Posted: 2021-07-23
First Post: 2007-06-20

Brief Title: ALTTO Adjuvant Lapatinib AndOr Trastuzumab Treatment Optimisation Study BIG 2-06N063D
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Neoplasms Breast
Keywords:
Name View
HER2neu gene amplified View
Adjuvant View
ErbB2-overexpressing View
Early stage breast cancer View